Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors
- Fariba Navid
- , Sharyn D. Baker
- , M. Beth McCarville
- , Clinton F. Stewart
- , Catherine A. Billups
- , Jianrong Wu
- , Andrew M. Davidoff
- , Sheri L. Spunt
- , Wayne L. Furman
- , Lisa M. McGregor
- , Shuiying Hu
- , John C. Panetta
- , David Turner
- , Demba Fofana
- , Wilburn E. Reddick
- , Wing Leung
- , Victor M. Santana
Research output: Contribution to journal › Article › peer-review
69
Scopus
citations